The Harvard Drug Group LLC recalls Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Di
Recalled April 22, 2026 · FDA recall D-0485-2026 · The Harvard Drug Group
Hazard
Failed Dissolution Specifications · FDA Class II
Units
N/A
Sold at
US Nationwide.
Description
Failed Dissolution Specifications
Product
Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61
Manufacturer(s)
The Harvard Drug Group LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →